Form 8-K - Current report:
SEC Accession No. 0001104659-23-103032
Filing Date
2023-09-22
Accepted
2023-09-22 09:00:37
Documents
13
Period of Report
2023-09-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2326714d1_8k.htm   iXBRL 8-K 27541
2 EXHIBIT 10.1 tm2326714d1_ex10-1.htm EX-10.1 1075786
  Complete submission text file 0001104659-23-103032.txt   1514853

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ptct-20230922.xsd EX-101.SCH 3009
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptct-20230922_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptct-20230922_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2326714d1_8k_htm.xml XML 3218
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 231270327
SIC: 2834 Pharmaceutical Preparations